Ascenta Capital

About

Ascenta Capital Translating Science into Medicines $335 Million Assets Under Management $15-30 Million Biotech Investments Ascenta Capital was born to help innovative companies as they grow from their scientific foundations to advance the clinical development of meaningful medicines for patients. We make concentrated investments and work in collaboration to support our management teams with our strategic and operational experience. 01. Deep Scientific Insight We make concentrated investments and work in collaboration to support our manag 02. Patient-Centered Approach We invest in innovations that have the power to make a meaningful difference in patients’ lives, keeping patient needs at the heart of every decision. 03. Strategic Growth Support Beyond capital, we provide strategic guidance, connections, and resources to help our partners scale effectively and sustainably. Our Strategy Phase 1 and 2 We partner with companies that have development candidates, translating their preclinical science into early human safety and efficiency data. Platforms We believe there lies opportunity in multi-medicine platforms. Complex questions of growth, strategy and value creation are front and center, and offer asymmetric upside Our Values Originate Conviction Act Decisively Be Collaborative Stay Nimble Patients are waiting. Biopharma’s essence is delivering innovative medicines to patients with major unmet needs. Management, scientists, clinical investigators, and investors all together st

Key Contact

Geographic Focus